A citation-based method for searching scientific literature

Bernard Portha, Cécile Tourrel-Cuzin, Jamileh Movassat. Exp Diabetes Res 2011
Times Cited: 45







List of co-cited articles
441 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Biology of incretins: GLP-1 and GIP.
Laurie L Baggio, Daniel J Drucker. Gastroenterology 2007
20


The physiology of glucagon-like peptide 1.
Jens Juul Holst. Physiol Rev 2007
17

Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets.
Loredana Farilla, Angela Bulotta, Boaz Hirshberg, Sergio Li Calzi, Nasif Khoury, Houtan Noushmehr, Cristina Bertolotto, Umberto Di Mario, David M Harlan, Riccardo Perfetti. Endocrinology 2003
474
17


cAMP promotes pancreatic beta-cell survival via CREB-mediated induction of IRS2.
Ulupi S Jhala, Gianluca Canettieri, Robert A Screaton, Rohit N Kulkarni, Stan Krajewski, John Reed, John Walker, Xueying Lin, Morris White, Marc Montminy. Genes Dev 2003
419
13




Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease.
Thomas Nyström, Mark K Gutniak, Qimin Zhang, Fan Zhang, Jens Juul Holst, Bo Ahrén, Ake Sjöholm. Am J Physiol Endocrinol Metab 2004
492
11

Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy.
Lazaros A Nikolaidis, Dariush Elahi, Teresa Hentosz, Aaron Doverspike, Rhonda Huerbin, Lee Zourelias, Carol Stolarski, You-tang Shen, Richard P Shannon. Circulation 2004
389
11

Glucagon-like peptide-1 inhibits pancreatic ATP-sensitive potassium channels via a protein kinase A- and ADP-dependent mechanism.
Peter E Light, Jocelyn E Manning Fox, Michael J Riedel, Michael B Wheeler. Mol Endocrinol 2002
113
11

Epac-selective cAMP analog 8-pCPT-2'-O-Me-cAMP as a stimulus for Ca2+-induced Ca2+ release and exocytosis in pancreatic beta-cells.
Guoxin Kang, Jamie W Joseph, Oleg G Chepurny, Marie Monaco, Michael B Wheeler, Johannes L Bos, Frank Schwede, Hans-G Genieser, George G Holz. J Biol Chem 2003
241
11

The biology of incretin hormones.
Daniel J Drucker. Cell Metab 2006
11

Glucagon-like peptide-1 prevents beta cell glucolipotoxicity.
J Buteau, W El-Assaad, C J Rhodes, L Rosenberg, E Joly, M Prentki. Diabetologia 2004
243
11

Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies.
Michael Elashoff, Aleksey V Matveyenko, Belinda Gier, Robert Elashoff, Peter C Butler. Gastroenterology 2011
549
11

Glucagon-like peptide-1 7-36: a physiological incretin in man.
B Kreymann, G Williams, M A Ghatei, S R Bloom. Lancet 1987
11





Glucagon-like peptide-1 increases beta-cell glucose competence and proliferation by translational induction of insulin-like growth factor-1 receptor expression.
Marion Cornu, Honey Modi, Dan Kawamori, Rohit N Kulkarni, Magali Joffraud, Bernard Thorens. J Biol Chem 2010
65
11

Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis.
Yazhou Li, Tanya Hansotia, Bernardo Yusta, Frederic Ris, Philippe A Halban, Daniel J Drucker. J Biol Chem 2003
464
8

International Union of Pharmacology. XXXV. The glucagon receptor family.
Kelly E Mayo, Laurence J Miller, Dominique Bataille, Stéphane Dalle, Burkhard Göke, Bernard Thorens, Daniel J Drucker. Pharmacol Rev 2003
322
8


Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans.
A Flint, A Raben, A Astrup, J J Holst. J Clin Invest 1998
931
8


Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways.
Kiwon Ban, M Hossein Noyan-Ashraf, Judith Hoefer, Steffen-Sebastian Bolz, Daniel J Drucker, Mansoor Husain. Circulation 2008
734
8

Incretin-based therapies for type 2 diabetes mellitus.
Julie A Lovshin, Daniel J Drucker. Nat Rev Endocrinol 2009
484
8



Glucagon-like peptide 1 induces natriuresis in healthy subjects and in insulin-resistant obese men.
Jean-Pierre Gutzwiller, Stefan Tschopp, Andreas Bock, Carlos E Zehnder, Andreas R Huber, Monika Kreyenbuehl, Heike Gutmann, Jürgen Drewe, Christoph Henzen, Burkhard Goeke,[...]. J Clin Endocrinol Metab 2004
275
8

Glucagon-like peptide 1 can directly protect the heart against ischemia/reperfusion injury.
Amal K Bose, Mihaela M Mocanu, Richard D Carr, Christian L Brand, Derek M Yellon. Diabetes 2005
453
8

Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats.
M Tang-Christensen, P J Larsen, R Göke, A Fink-Jensen, D S Jessop, M Møller, S P Sheikh. Am J Physiol 1996
448
8



Glucagon-like peptide-1 mobilizes intracellular Ca2+ and stimulates mitochondrial ATP synthesis in pancreatic MIN6 beta-cells.
Takashi Tsuboi, Gabriela da Silva Xavier, George G Holz, Laurence S Jouaville, Andrew P Thomas, Guy A Rutter. Biochem J 2003
157
8

Anchoring of protein kinase A facilitates hormone-mediated insulin secretion.
L B Lester, L K Langeberg, J D Scott. Proc Natl Acad Sci U S A 1997
163
8

Role of the cAMP sensor Epac as a determinant of KATP channel ATP sensitivity in human pancreatic beta-cells and rat INS-1 cells.
Guoxin Kang, Colin A Leech, Oleg G Chepurny, William A Coetzee, George G Holz. J Physiol 2008
60
8

Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down?
M A Nauck, I Vardarli, C F Deacon, J J Holst, J J Meier. Diabetologia 2011
305
8

A nonpeptidic agonist of glucagon-like peptide 1 receptors with efficacy in diabetic db/db mice.
Desu Chen, Jiayu Liao, Na Li, Caihong Zhou, Qing Liu, Guangxing Wang, Rui Zhang, Song Zhang, Lilin Lin, Kaixian Chen,[...]. Proc Natl Acad Sci U S A 2007
128
8

Therapy in the early stage: incretins.
Simona Cernea, Itamar Raz. Diabetes Care 2011
74
8

Glucagon-like peptide-1 infusion improves left ventricular ejection fraction and functional status in patients with chronic heart failure.
George G Sokos, Lazaros A Nikolaidis, Sunil Mankad, Dariush Elahi, Richard P Shannon. J Card Fail 2006
476
8

Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion.
Lazaros A Nikolaidis, Sunil Mankad, George G Sokos, Glen Miske, Ankur Shah, Dariush Elahi, Richard P Shannon. Circulation 2004
649
8

Downregulation of GLP-1 and GIP receptor expression by hyperglycemia: possible contribution to impaired incretin effects in diabetes.
Gang Xu, Hideaki Kaneto, D Ross Laybutt, Valerie F Duvivier-Kali, Nitin Trivedi, Kiyoshi Suzuma, George L King, Gordon C Weir, Susan Bonner-Weir. Diabetes 2007
266
8

Glucagon-like peptide (GLP)-1(9-36)amide-mediated cytoprotection is blocked by exendin(9-39) yet does not require the known GLP-1 receptor.
Kiwon Ban, Kyoung-Han Kim, Chan-Kyung Cho, Meghan Sauvé, Eleftherios P Diamandis, Peter H Backx, Daniel J Drucker, Mansoor Husain. Endocrinology 2010
159
8

Glucose sensing in L cells: a primary cell study.
Frank Reimann, Abdella M Habib, Gwen Tolhurst, Helen E Parker, Gareth J Rogers, Fiona M Gribble. Cell Metab 2008
512
8

Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line.
D J Drucker, J Philippe, S Mojsov, W L Chick, J F Habener. Proc Natl Acad Sci U S A 1987
628
8

GLP-1 receptor activation improves beta cell function and survival following induction of endoplasmic reticulum stress.
Bernardo Yusta, Laurie L Baggio, Jennifer L Estall, Jackie A Koehler, Dianne P Holland, Hongyun Li, Danny Pipeleers, Zhidong Ling, Daniel J Drucker. Cell Metab 2006
289
8

Protein kinase Czeta activation mediates glucagon-like peptide-1-induced pancreatic beta-cell proliferation.
J Buteau, S Foisy, C J Rhodes, L Carpenter, T J Biden, M Prentki. Diabetes 2001
193
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.